Magnetic Resonance Imaging (MRI) Scan
Magnetic Resonance Imaging (MRI) Scan is a medical device with 10 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
3
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Advanced Diffusion Imaging in Renal Cancer Patients
Serotonin Release in Premotor and Motor PD
Longitudinal Investigation of I2BS in PD
EMRI SureScan™ Clinical Study
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Clinical Trials (10)
Advanced Diffusion Imaging in Renal Cancer Patients
Serotonin Release in Premotor and Motor PD
Longitudinal Investigation of I2BS in PD
EMRI SureScan™ Clinical Study
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer
ProMRI Study of the Entovis Pacemaker System
Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa
ProMRI Study of the Iforia ICD System (Phase C)
ProMRI Study of the Entovis Pacemaker System (Phase B)
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10